Kratom

 Kratom (Mitragyna speciosa)

What it is

• A tropical tree native to Southeast Asia. Leaves contain active alkaloids—primarily mitragynine and 7‑hydroxymitragynine.
• Sold in the U.S. as powders, capsules, teas, extracts. Potency varies widely between products and batches.

How it works (overview)

• Mitragynine and 7‑hydroxymitragynine act at mu‑opioid receptors (partial agonism) and also affect adrenergic and serotonergic systems. Effects depend on dose, product, and individual factors.

Common effects

• Lower doses: more stimulating/energizing, increased alertness.
• Higher doses: more sedating/analgesic, euphoria, nausea.
• Onset typically within 15–45 minutes by mouth; effects can last several hours.

Why people use it

• Self‑treatment for pain, anxiety, low mood, fatigue, or to self‑manage opioid withdrawal. Evidence for effectiveness is limited and mixed; kratom is not FDA‑approved for any medical indication.

Risks and side effects

• Common: nausea, vomiting, constipation, dry mouth, sweating, dizziness, itching, appetite/weight changes, insomnia or drowsiness.
• Mental health: anxiety, irritability, depressed mood; with heavy or long‑term use, dependence can develop.
• Withdrawal (after frequent/heavy use): muscle aches, insomnia, runny nose, diarrhea, restlessness, irritability, low mood, cravings; usually begins within a day after last use.
• Serious but less common: seizures, liver injury (can present with dark urine, jaundice, severe fatigue/abdominal pain), heart rhythm changes/QTc prolongation, severe sedation/respiratory depression—especially with other depressants.
• Product risks: contamination or adulteration (e.g., heavy metals, bacteria, added opioids or other drugs). Potency is highly variable even within the same “strain” name.

Dangerous interactions

• Do NOT combine with alcohol, opioids (e.g., oxycodone, heroin, methadone, buprenorphine unless under medical supervision), benzodiazepines (e.g., Xanax, Valium), barbiturates, or other sedatives—risk of profound sedation and breathing suppression.
• Use extreme caution with antidepressants and other serotonergic drugs (SSRIs/SNRIs, MAOIs, triptans, linezolid, St. John’s wort)—possible serotonin toxicity.
• May inhibit liver enzymes (notably CYP3A4 and CYP2D6), potentially raising levels of many medicines (certain antidepressants, antipsychotics, beta‑blockers, antiarrhythmics, opioids, some ADHD meds). If you take prescription meds, speak with a clinician or pharmacist.
• Other risks with stimulants (cocaine, methamphetamine) and cannabis due to unpredictable combined effects.

Regulatory status (U.S.)

• The FDA has warned against kratom’s use and has not approved it for any medical purposes. Legal status varies by state and city; some jurisdictions restrict or ban sales/possession. Check your current local and federal laws before purchasing or using.

Special situations

• Pregnancy/breastfeeding: avoid—potential risks to the fetus/infant and neonatal withdrawal have been reported.
• Liver/kidney disease, heart rhythm problems, seizure disorders, or substance use disorders: higher risk—avoid or use only under medical guidance.
• Driving/operating machinery: avoid, especially at higher doses or with any sedating effects.

Harm‑reduction tips (if you choose to use)

• Avoid mixing with any depressants (alcohol, opioids, benzodiazepines) or with serotonergic drugs.
• Start low, go slow; avoid concentrated extracts. Don’t redose rapidly.
• Use only one new product at a time; avoid daily use to reduce dependence risk.
• Stay hydrated; take with food if nausea occurs.
• Stop and seek medical care urgently for trouble breathing, fainting, severe confusion, seizures, persistent vomiting, yellowing of eyes/skin, or very dark urine.
• Consider buying from vendors that provide batch testing certificates, though this is not a guarantee of safety.